Aviado · Research
Longevity Daily
Sunday, August 23, 2026
Listen
Today's Brief
Today's standout finding: a single blood draw can now reveal the biological age of each of your organs independently, with gaps between organs sometimes spanning decades. That story leads an edition that also examines why high-dose flu vaccination is linked to significantly lower Alzheimer's risk in adults over 65 — a finding with immediate fall vaccination implications. On the supplement front, metformin's longevity promise gets a frank evidence check, and Health.com rounds up what top longevity experts actually take — and skip. Aviado Research also weighs in with original analysis rounding out a strong edition.
10 stories3 peer-reviewed1 Aviado original
Cognitive Health & Neuroprotection
High-Dose Flu Vaccination Linked to Lower Alzheimer's Risk in Adults Over 65
A large US claims-based cohort study found that adults aged 65 and older who received the high-dose influenza vaccine had a significantly lower incidence of Alzheimer's dementia compared to those who received the standard dose. The finding adds to mounting evidence that chronic neuroinflammation — which influenza can trigger or worsen — is a meaningful driver of dementia risk. If you're over 65, it's worth specifically requesting the high-dose formulation from your doctor this fall; it may be doing more work than you realize.
Read more →Neuriva Is Everywhere — But Does the Science Hold Up?
Pharmacy Times takes a rigorous look at Neuriva, one of the best-selling brain supplement lines in the US, dissecting the evidence behind its core ingredients — phosphatidylserine and coffee cherry extract. The verdict: some ingredients carry modest supporting data, but manufacturer claims around memory, accuracy, and focus have not been evaluated by the FDA, and endorsements by celebrity neuroscientist Mayim Bialik do a lot of heavy lifting. Worth reading before spending on a product that markets hard on credibility it hasn't fully earned.
Read more →Supplements & Compounds
Metformin: The Cheapest Longevity Drug in the World Still Cannot Prove It Works
A new consolidated review from Hamad Bin Khalifa University maps metformin's actions across all 12 hallmarks of aging — tracing a mechanistic chain from mitochondrial complex I inhibition through AMPK activation to mTOR suppression, autophagy, and epigenetic remodeling. The pathway science is genuinely compelling. But after 60 years and widespread off-label use in healthy adults, metformin still lacks clinical proof of lifespan extension in non-diabetic humans — and this review rates the evidence strength candidly for each hallmark. Essential reading if you're taking it for longevity reasons.
Read more →The Supplements Longevity Experts Actually Take — and Which Ones They Skip
Health.com canvassed leading longevity physicians and researchers on their personal supplement stacks, separating what the evidence actually supports from what gets hyped. Some widely marketed products land firmly on the skip list, while a handful of evidence-backed compounds show up consistently across expert shelves. This is a useful shortcut for filtering signal from noise in a supplement market that generates far more marketing than clinical data.
Read more →Research & Papers
A Single Blood Sample Can Now Reveal the Biological Age of Each of Your Organs
A team led by André Rendeiro analyzed 25,712 samples and found that a single blood draw can estimate the biological age of individual organs independently — meaning your liver may be aging far faster than your heart, or your kidneys may clock in younger than your birth certificate suggests. The organ-specific divergence can span decades within the same person, a pattern invisible to whole-body biological age scores. This could fundamentally change how doctors identify disease risk before symptoms arrive, and points toward a future where routine blood panels flag which organs need the most attention first.
Read more →A 47-Year-Old Scientist Tracked Himself for Months — His Biological Age Fell to 32
Published in PLOS ONE, the DELTA protocol enrolled a 47-year-old scientist in an intensive N=1 digital health study combining wearables, dynamic biomarkers, and personalized feedback loops. By the study's end, his measured biological age had reportedly dropped to 32 — a 15-year reversal. Single-subject studies can't be generalized, but the methodological rigor here is notable, and the protocol's modular design provides a practical blueprint for self-quantifiers interested in tracking real-time biological age change.
Read more →Immune Aging Follows Strikingly Different Paths in Men and Women
A study published in npj Aging found that immune aging trajectories diverge significantly between the sexes, with distinct hormonal and epigenetic mechanisms driving the differences — with implications for vaccine efficacy, autoimmune risk, and the effectiveness of senolytic and mTOR-targeting therapies. The practical upshot: one-size-fits-all immune longevity strategies may systematically miss the mark for women. The authors flag specific therapeutic targets — including the Menin-Bach2 axis — that could enable sex-tailored immune interventions.
Read more →Aviado Research: New Analysis on Longevity Science
Aviado Research's latest piece digs into the current state of longevity science with the editorial team's characteristic evidence-first framing. As biological age measurement tools and intervention data continue to mature rapidly, Aviado's analysis helps separate durable findings from premature conclusions. Well worth your time if you want a curated perspective on where the field actually stands.
Read the full Aviado analysis →Lifestyle & Nutrition
A Longevity Doctor Has a 1 A.M. Bedtime — Here's How He Still Ticks All the Boxes
Dr. Primas, a 66-year-old physician who has practiced longevity medicine for decades, opens up about the daily habits he actually keeps — including a late bedtime that breaks one of the field's most repeated rules. His core thesis: the trajectory toward chronic disease begins years before any symptom, and consistent optimization across multiple domains matters more than perfection on any single metric. The profile is a useful reality check on what an evidence-informed longevity practice looks like when it has to coexist with a real life.
Read more →Industry & Policy
Americans Now Spend $3 Billion a Year on Longevity Supplements for Their Pets
Pet owners are mirroring human biohacking trends at scale — spending hundreds of dollars monthly on rapamycin, peptides, and NAD precursors for their dogs and cats, pushing the pet longevity supplement market to $3 billion annually. The catch, noted bluntly in the piece: clinical trials haven't proven most of these interventions actually extend animal lifespan. It's a sharp mirror for the human longevity supplement market, which faces identical evidentiary gaps — just with considerably more consumer awareness of the uncertainty.
Read more →